Successful anticoagulation for bilateral central retinal vein occlusion

Clinica Chimica Acta

Volumn 412, Issue 11-12, 2011, Pages 1165-1166

  Glueck, Charles J ^a   Hutchins, Robert K ^b   Khan, Ayub ^a   Bains, Puneetpal S ^a   Khan, Naseer ^a   Wang, Ping ^a  

^a Jewish Hospital of Cincinnati   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CORTICOSTEROID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

AGED; ANTICOAGULANT THERAPY; CANNULATION; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; COLOR VISION DEFECT; EYE EXAMINATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LASER COAGULATION; LETTER; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA MACULA EDEMA; THROMBOPHILIA; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; FEMALE; HUMANS; RETINAL VEIN; RETINAL VEIN OCCLUSION;

EID: 79955022754     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.02.027     Document Type: Letter

References (21)

1. Hayreh S.S. Management of central retinal vein occlusion. Ophthalmologica 2003, 217:167-188.
2. Rehak M., Muller M., Scholz M., Wiercinska J., Niederwieser D., Wiedemann P. Antiphospholipid syndrome and retinal vein occlusion. Meta-analysis of published studies. Ophthalmologe 2009, 106:427-434.
3. Hayreh S.S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005, 24:493-519.
4. Lee Y.H., Lee J.Y., Kim Y.S., Kim D.H., Kim J. Successful anticoagulation for bilateral central retinal vein occlusions accompanied by cerebral venous thrombosis. Arch Neurol 2006, 63:1648-1651.
5. Yap Y.C., Barampouti F. Central retinal vein occlusion secondary to protein S deficiency. Ann Ophthalmol (Skokie) 2007, 39:343-344.
6. Greiner K., Hafner G., Dick B., Peetz D., Prellwitz W., Pfeiffer N. Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 1999, 128:69-74.
7. Rehak M., Krcova V., Slavik L., Muller M., Rehak J. Protein S deficiency with homozygous factor V Leiden mutation in central retinal vein occlusion. Vol. 42[4]. Can J Ophthalmol 2007, 42:875. author reply 6.
8. Glueck C.J., Ping W., Hutchins R., Petersen M.R., Golnik K. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions. Clin Appl Thromb Hemost 2008, 14:286-294.
9. Glueck C.J., Wang P., Bell H., Rangaraj V., Goldenberg N. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost 2005, 11:375-389.
10. Janssen M.C., den Heijer M., Cruysberg J.R., Wollersheim H., Bredie S.J. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005, 93:1021-1026.
11. Rehak M., Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010, 8:1886-1894.
12. Mohamed Q., McIntosh R.L., Saw S.M., Wong T.Y. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007, 114:507-519. 24.
13. Lazo-Langner A., Hawel J., Ageno W., Kovacs M.J. Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials. Haematologica 2010, 95:1587-1593.
14. Squizzato A., Manfredi E., Bozzato S., Dentali F., Ageno W. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. Thromb Haemost 2010, 103:271-276.
15. Turello M., Pasca S., Daminato R., et al. Retinal vein occlusion: evaluation of "classic" and "emerging" risk factors and treatment. J Thromb Thrombolysis 2010, 29:459-464.
16. Kuhli-Hattenbach C., Scharrer I., Luchtenberg M., Hattenbach L.O. Selective thrombophilia screening of young patients with retinal vein occlusion. Klin Monatsbl Augenheilkd 2009, 226:768-773.
17. Rehak M., Krcova V., Fric E., et al. Disturbances of the plasma coagulation defects in retinal venous occlusions. Cesk Slov Oftalmol 2008, 64:108-111.
18. Sodi A., Giambene B., Marcucci R., et al. Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion. Eur J Ophthalmol 2008, 18:233-238.
19. Greiner K., Peetz D., Winkgen A., Prellwitz W., Pfeiffer N., Hafner G. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 1999, 23:155-160.
20. Salim S., Lam W.C., Hanna W. Central retinal vein occlusion with therapeutic level of anticoagulation. Case Rep Med 2009, 2009:827982.
21. Koizumi H., Ferrara D.C., Brue C., Spaide R.F. Central retinal vein occlusion case-control study. Am J Ophthalmol 2007, 144:858-863.